Role of the renin-angiotensin system in pregnancy and preeclampsia
Copyright © 2020 SEH-LELHA. Publicado por Elsevier España, S.L.U. All rights reserved..
The renin-angiotensin system (ARS) is a hormonal cascade that regulates blood pressure, electrolytes and water balance. AngiotensinII (AII) exerts its effects through the AT1 and AT2 receptors. AT1 is found in the syncytiotrophoblast, AT2 predominates during foetal development and its stimulation inhibits cell growth, increases apoptosis, causes vasodilation and regulates the development of foetal tissue. There is also an SRA in the placenta. The local generation of AII is responsible for the activation of AT1 receptors in the trophoblast. In normal pregnancy, concomitantly with reduction of blood pressure the circulating RAS increases, but blood pressure does not rise due to AII refractoriness, which does not occur in preeclampsia. We review the role of the SRA in normal pregnancy and preeclampsia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Hipertension y riesgo vascular - 37(2020), 2 vom: 01. Apr., Seite 72-77 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Papel del sistema renina-angiotensina en el embarazo y la preeclampsia |
---|
Beteiligte Personen: |
Martell Claros, N [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 29.04.2021 Date Revised 29.04.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.hipert.2020.02.003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM307359026 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM307359026 | ||
003 | DE-627 | ||
005 | 20231225125406.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||spa c | ||
024 | 7 | |a 10.1016/j.hipert.2020.02.003 |2 doi | |
028 | 5 | 2 | |a pubmed24n1024.xml |
035 | |a (DE-627)NLM307359026 | ||
035 | |a (NLM)32147515 | ||
035 | |a (PII)S1889-1837(20)30006-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Martell Claros, N |e verfasserin |4 aut | |
245 | 1 | 0 | |a Role of the renin-angiotensin system in pregnancy and preeclampsia |
246 | 3 | 3 | |a Papel del sistema renina-angiotensina en el embarazo y la preeclampsia |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.04.2021 | ||
500 | |a Date Revised 29.04.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 SEH-LELHA. Publicado por Elsevier España, S.L.U. All rights reserved. | ||
520 | |a The renin-angiotensin system (ARS) is a hormonal cascade that regulates blood pressure, electrolytes and water balance. AngiotensinII (AII) exerts its effects through the AT1 and AT2 receptors. AT1 is found in the syncytiotrophoblast, AT2 predominates during foetal development and its stimulation inhibits cell growth, increases apoptosis, causes vasodilation and regulates the development of foetal tissue. There is also an SRA in the placenta. The local generation of AII is responsible for the activation of AT1 receptors in the trophoblast. In normal pregnancy, concomitantly with reduction of blood pressure the circulating RAS increases, but blood pressure does not rise due to AII refractoriness, which does not occur in preeclampsia. We review the role of the SRA in normal pregnancy and preeclampsia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Albúmina sérica | |
650 | 4 | |a Embarazo | |
650 | 4 | |a Haemodynamics during preeclampsia | |
650 | 4 | |a Hemodinámica en preeclampsia | |
650 | 4 | |a Oncotic pressure | |
650 | 4 | |a Preeclampsia | |
650 | 4 | |a Pregnancy | |
650 | 4 | |a Presión oncótica | |
650 | 4 | |a Renin-angiotensin system | |
650 | 4 | |a Serum albumin | |
650 | 4 | |a Sistema renina-angiotensina | |
650 | 7 | |a Receptor, Angiotensin, Type 1 |2 NLM | |
650 | 7 | |a Receptor, Angiotensin, Type 2 |2 NLM | |
650 | 7 | |a Angiotensin II |2 NLM | |
650 | 7 | |a 11128-99-7 |2 NLM | |
700 | 1 | |a Asenjo de la Fuente, J E |e verfasserin |4 aut | |
700 | 1 | |a Abad Cardiel, M |e verfasserin |4 aut | |
700 | 1 | |a García Donaire, J A |e verfasserin |4 aut | |
700 | 1 | |a Herráiz, M A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Hipertension y riesgo vascular |d 2015 |g 37(2020), 2 vom: 01. Apr., Seite 72-77 |w (DE-627)NLM250932563 |x 1989-4805 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2020 |g number:2 |g day:01 |g month:04 |g pages:72-77 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.hipert.2020.02.003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2020 |e 2 |b 01 |c 04 |h 72-77 |